2004
Increase in Sexual Risk Behavior Associated with Immunologic Response to Highly Active Antiretroviral Therapy among HIV-Infected Injection Drug Users
Tun W, Gange S, Vlahov D, Strathdee S, Celentano D. Increase in Sexual Risk Behavior Associated with Immunologic Response to Highly Active Antiretroviral Therapy among HIV-Infected Injection Drug Users. Clinical Infectious Diseases 2004, 38: 1167-1174. PMID: 15095224, DOI: 10.1086/383033.Peer-Reviewed Original ResearchConceptsInjection drug usersActive antiretroviral therapyHAART initiationCell countAntiretroviral therapyDrug usersSexual intercourseRisk reduction counselingHuman immunodeficiency virusLarge cohort studyDrug injection behaviorInjection of drugsUnprotected sexual intercourseSemiannual visitsReduction counselingCohort studyHIV infectionHIV serostatusImmunodeficiency virusImmunologic responseNeedle sharingBlood samplesSurvival analysisRisk behaviorsCD4
2001
Longitudinal Study of Condom Use Patterns Among Women With or at Risk for HIV
Moore J, Hamburger M, Vlahov D, Schoenbaum E, Schuman P, Mayer K. Longitudinal Study of Condom Use Patterns Among Women With or at Risk for HIV. AIDS And Behavior 2001, 5: 263-273. DOI: 10.1023/a:1011344727416.Peer-Reviewed Original ResearchUninfected womenCondom use patternsConsistent condom useCondom useInfected partnerInfected womenSafe sex counselingUninfected male partnersInconsistent condom useLongitudinal studyGreater condom useHIV infectionActive HIVHIV serostatusUnknown serostatusPartner serostatusUninfected partnersStudy visitActive womenHIVSerostatusMale partnersWomenComparison groupVisitsUse of Audio Computer-assisted Self-Interviews to Assess Tuberculosis-related Risk Behaviors
RILEY E, CHAISSON R, ROBNETT T, VERTEFEUILLE J, STRATHDEE S, VLAHOV D. Use of Audio Computer-assisted Self-Interviews to Assess Tuberculosis-related Risk Behaviors. American Journal Of Respiratory And Critical Care Medicine 2001, 164: 82-85. PMID: 11435243, DOI: 10.1164/ajrccm.164.1.2101091.Peer-Reviewed Original ResearchConceptsInterviewer-assisted questionnaireComputer-assisted questionnaireHIV infectionRisk factorsOdds ratioHuman immunodeficiency virus risk factorsSelf-reported tuberculosisMultiple logistic regressionRisk behavior dataFinal multivariate modelSmoking equipmentNeedle exchange programsNeedle exchange program participantsHigh-risk behaviorsUnderwent interviewsHIV serostatusAlcohol intakeCigarette smokingDrug useHealth statusRisk behaviorsTuberculosisSmoking marijuanaLogistic regressionMultivariate model
2000
Prevention of HIV Infection in Street-Recruited Injection Drug Users
Monterroso E, Hamburger M, Vlahov D, Jarlais D, Ouellet L, Altice F, Byers R, Kerndt P, Watters J, Bowser B, Fernando D, Holmberg S. Prevention of HIV Infection in Street-Recruited Injection Drug Users. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2000, 25: 63-70. DOI: 10.1097/00126334-200009010-00009.Peer-Reviewed Original ResearchConceptsInjection drug usersDrug usersHIV infectionInitial serum specimensLarge multicity studyHIV prevention strategiesHIV infection riskHIV prevention programsSyringe exchange programsDrug treatment programsUse of needlesNew AIDSHIV acquisitionHIV serostatusHIV casesPrevention strategiesSerum specimensSex partnersInfection ratePrevention programsTreatment programInfection riskStandard questionnaireHIVMultivariate modelCorrelates of enrollment in methadone maintenance treatment programs differ by HIV-serostatus
Shah N, Celentano D, Vlahov D, Stambolis V, Johnson L, Nelson K, Strathdee S. Correlates of enrollment in methadone maintenance treatment programs differ by HIV-serostatus. AIDS 2000, 14: 2035-2043. PMID: 10997409, DOI: 10.1097/00002030-200009080-00020.Peer-Reviewed Original ResearchMeSH KeywordsAdultBaltimoreCohort StudiesFemaleHealth Services AccessibilityHIV AntibodiesHIV InfectionsHIV SeronegativityHIV SeropositivityHumansMaleMethadoneMiddle AgedNeedle-Exchange ProgramsProspective StudiesRisk-TakingSocioeconomic FactorsSubstance Abuse Treatment CentersSubstance Abuse, IntravenousConceptsMethadone maintenance treatment programInjection drug usersMaintenance treatment programNeedle exchange programsHIV serostatusHIV-seronegative injection drug usersSeronegative injection drug usersHIV-negative injection drug usersTreatment programHIV-seropositive participantsHealth care providersTreatment slotsNeedle exchange program participantsAfrican AmericansHIV testProspective cohortCare providersDrug usersProgram attendanceOlder ageCertain subgroupsVulnerable populationsSimilar proportionsBehavioral factorsEnrollmentPrevention of HIV Infection in Street-Recruited Injection Drug Users
Monterroso E, Hamburger M, Vlahov D, Jarlais D, Ouellet L, Altice F, Byers R, Kerndt P, Watters J, Bowser B, Fernando M, Holmberg S. Prevention of HIV Infection in Street-Recruited Injection Drug Users. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2000, 25: 63-70. PMID: 11064506, DOI: 10.1097/00042560-200009010-00009.Peer-Reviewed Original ResearchConceptsInjection drug usersDrug usersHIV infectionInitial serum specimensLarge multicity studyHIV prevention strategiesHIV infection riskHIV prevention programsSyringe exchange programsDrug treatment programsUse of needlesNew AIDSHIV acquisitionHIV serostatusHIV casesPrevention strategiesSerum specimensSex partnersInfection ratePrevention programsTreatment programInfection riskStandard questionnaireHIVMultivariate modelCervical Neoplasia and Repeated Positivity of Human Papillomavirus Infection In Human Immunodeficiency Virus-seropositive and -seronegative Women
Ahdieh L, Munoz A, Vlahov D, Trimble C, Timpson L, Shah K. Cervical Neoplasia and Repeated Positivity of Human Papillomavirus Infection In Human Immunodeficiency Virus-seropositive and -seronegative Women. American Journal Of Epidemiology 2000, 151: 1148-1157. PMID: 10905527, DOI: 10.1093/oxfordjournals.aje.a010165.Peer-Reviewed Original ResearchMeSH KeywordsAdultAntiviral AgentsCD4 Lymphocyte CountFemaleHIV InfectionsHIV SeronegativityHIV SeropositivityHumansImmunosuppression TherapyIncidenceLongitudinal StudiesPapillomaviridaePapillomavirus InfectionsRisk AssessmentSurvival AnalysisTumor Virus InfectionsUterine Cervical DysplasiaUterine Cervical NeoplasmsConceptsCervical intraepithelial neoplasiaHuman papillomavirus infectionHPV positivityHPV clearancePapillomavirus infectionHIV infectionBiopsy-confirmed cervical intraepithelial neoplasiaAssociation of HIVPotent antiretroviral therapyCervicovaginal lavage specimensHuman immunodeficiency virusCells/Reversal of immunosuppressionPolymerase chain reaction-based assaySeronegative womenAntiretroviral therapyHIV- womenHPV resultsHIV- participantsHPV DNACervical neoplasiaHIV serostatusIntraepithelial neoplasiaImmunodeficiency virusRelated immunosuppressionIncreased Frequency of Overdose Deaths Among HIV-Infected Injection Drug Users
Vlahov D, Tang A, Lyles C, Rezza G, Thomas D, Cohn S, Macalino G, Stambolis V, Nelson K. Increased Frequency of Overdose Deaths Among HIV-Infected Injection Drug Users. Addiction Research & Theory 2000, 8: 311-326. DOI: 10.3109/16066350009009518.Peer-Reviewed Original ResearchInjection drug usersCause-specific mortalityHTV infectionOverdose deathsDrug usersUninfected personsPerson-time techniquesOverall mortality rateFrequency of AIDSOnset of AIDSCorrelates of deathMedian ageHIV serostatusPerson yearsExcess riskDrug overdoseMortality ratePoisson regressionRecord searchUnderlying causeInfectionMortalityDeathAIDSBaseline
1999
Needle-exchange attendance and health care utilization promote entry into detoxification
Strathdee S, Celentano D, Shah N, Lyles C, Stambolis V, Macalino G, Nelson K, Vlahov D. Needle-exchange attendance and health care utilization promote entry into detoxification. Journal Of Urban Health 1999, 76: 448-460. PMID: 10609594, PMCID: PMC3456698, DOI: 10.1007/bf02351502.Peer-Reviewed Original ResearchConceptsUninfected injection drug usersInjection drug usersNeedle exchange programsNeedle exchange attendanceDrug abuse treatmentHospital admissionDrug usersHuman immunodeficiency virus testAbuse treatmentImportant public health goalHIV-seronegative subjectsHealth care utilizationOutpatient medical careHealth care providersRecent drug usePublic health goalsIndependent predictorsCare utilizationHIV serostatusDetoxification admissionsCare providersVirus testHIVNeedle exchangeDrug use
1998
Socially desirable response tendency as a correlate of accuracy of self‐reported HIV serostatus for HIV seropositive injection drug users
Latkin C, Vlahov D. Socially desirable response tendency as a correlate of accuracy of self‐reported HIV serostatus for HIV seropositive injection drug users. Addiction 1998, 93: 1191-1197. PMID: 9813900, DOI: 10.1046/j.1360-0443.1998.93811917.x.Peer-Reviewed Original ResearchConceptsSelf-reported HIV serostatusSocial desirabilityInjection drug usersCorrelates of accuracyDesirable response tendenciesHIV serostatusDrug usersResponse tendenciesDesirable respondingHIV-seronegative participantsALIVE studyPredictive validityHIV-seropositive injection drug usersActive injection drug usersLongitudinal studySeropositive injection drug usersPositive predictive value 97Higher scoresHIV-seropositive participantsHIV prevention studyQuestionable validityNegative predictive valueParticipantsSeronegative participantsSeropositive participants
1997
Postcoital Vaginal Bleeding as a Risk Factor for Transmission of the Human Immunodeficiency Virus in a Heterosexual Partner Study in Brazil
Guimarães M, Vlahov D, Castilho E. Postcoital Vaginal Bleeding as a Risk Factor for Transmission of the Human Immunodeficiency Virus in a Heterosexual Partner Study in Brazil. JAMA Internal Medicine 1997, 157: 1362-1368. PMID: 9201011, DOI: 10.1001/archinte.1997.00440330102012.Peer-Reviewed Original ResearchConceptsPostcoital vaginal bleedingHIV infectionVaginal bleedingRisk factorsAnal sexMale partnersPostcoital bleedingFemale partnersCondom useHuman immunodeficiency virus (HIV) transmissionSexual contactAdvanced HIV infectionHuman immunodeficiency virusInconsistent condom useHIV positivityAIDS CenterHIV serostatusImmunodeficiency syndromeImmunodeficiency virusHeterosexual contactBleedingEligibility criteriaVaginal sexPartner studiesInfection
1996
Human Immunodeficiency Virus Infection and Infective Endocarditis among Injecting Drug Users
Manoff S, Vlahov D, Herskowitz A, Solomon L, Munoz A, Cohn S, Willoughby S, Nelson K. Human Immunodeficiency Virus Infection and Infective Endocarditis among Injecting Drug Users. Epidemiology 1996, 7: 566-570. PMID: 8899380, DOI: 10.1097/00001648-199611000-00002.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virus (HIV) infectionHIV-seropositive subjectsImmunodeficiency virus infectionInfective endocarditisDrug usersCD4 cellsOdds ratioVirus infectionHistory of endocarditisRisk of endocarditisHIV-seronegative subjectsInjection drug useInjecting Drug UsersCase-control studyConditional logistic regressionRace/ethnicitySubsequent endocarditisOngoing cohortHIV infectionSerious complicationsHIV serostatusEnrollment dateLast visitCohort enrollmentEndocarditis casesHIV testing behaviors in a population of inner-city women at high risk for HIV infection.
Solomon L, Moore J, Gleghorn A, Astemborski J, Vlahov D. HIV testing behaviors in a population of inner-city women at high risk for HIV infection. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1996, 13: 267-72. PMID: 8898672, DOI: 10.1097/00042560-199611010-00009.Peer-Reviewed Original ResearchConceptsHIV testHIV testingRisk behaviorsMultiple HIV testsPrior HIV testPrior HIV testingHIV testing historyInjection drug useHIV testing behaviorsHIV risk behaviorsInner-city womenHIV risk practicesMore sex partnersHigh-risk practicesHIV infectionHIV serostatusHIV StudyHigh riskRisk counselingSex partnersTesting historyDrug useSociodemographic characteristicsTesting behaviorWomen
1994
Drug‐related behavior change for HIV transmission among American injection drug users
CELENTANO D, MUÑOZ A, CORN S, NELSON K, VLAHOV D. Drug‐related behavior change for HIV transmission among American injection drug users. Addiction 1994, 89: 1309-1317. PMID: 7804092, DOI: 10.1111/j.1360-0443.1994.tb03310.x.Peer-Reviewed Original ResearchConceptsInjection drug usersSeropositive injection drug usersRisk behaviorsHIV infectionDrug usersActive injection drug usersDrug-related risk behaviorsHuman immunodeficiency virus (HIV) transmissionHigh-risk drug-related behaviorsSemi-annual visitsMultiple logistic regressionBehavior changeGreater risk reductionDrug-related behaviorsLow-risk behaviorsSeropositive participantsHIV serostatusHIV transmissionLongitudinal cohortVaccine developmentPrevention programsLogistic regressionAIDS epidemicVirus transmissionBehavior maintenanceImpact of HIV infection on non-AIDS mortality among Italian injecting drug users
Zaccarelli M, Gattari P, Rezza G, Conti S, Spizzichino L, Vlahov D, Ippolito G, Lelli V, Valenzi C. Impact of HIV infection on non-AIDS mortality among Italian injecting drug users. AIDS 1994, 8: 345-350. PMID: 8031512, DOI: 10.1097/00002030-199403000-00008.Peer-Reviewed Original ResearchConceptsHIV seropositivesHIV serostatusAIDS mortalityMortality rateAge-adjusted standardized mortality ratiosDrug usersHIV-negative IDUsHIV-seronegative IDUsHIV-seropositive IDUPerson-time techniquesStandardized mortality ratioCause-specific mortalityDrug treatment centersRate of deathHIV-seronegativesPossible HIVHIV infectionHIV testingProspective studyMortality ratioExcess mortalityGeneral populationOverdose mortalityAIDS causesHIV
1993
Socially desirable responding and self‐reported HIV infection risk behaviors among intravenous drug users
LATKIN C, VLAHOV D, ANTHONY J. Socially desirable responding and self‐reported HIV infection risk behaviors among intravenous drug users. Addiction 1993, 88: 517-526. PMID: 8485429, DOI: 10.1111/j.1360-0443.1993.tb02058.x.Peer-Reviewed Original Research
1991
Utilization of health services in a cohort of intravenous drug users with known HIV-1 serostatus.
Solomon L, Frank R, Vlahov D, Astemborski J. Utilization of health services in a cohort of intravenous drug users with known HIV-1 serostatus. American Journal Of Public Health 1991, 81: 1285-90. PMID: 1928527, PMCID: PMC1405342, DOI: 10.2105/ajph.81.10.1285.Peer-Reviewed Original ResearchConceptsIntravenous drug usersCD4 cell countDrug usersHealth servicesHIV serostatusClinical symptomsHIV-seropositive intravenous drug usersHealth insuranceCell countAsymptomatic HIV-1 infectionSeropositive intravenous drug usersHuman immunodeficiency virus (HIV) infectionHIV-seropositive drug usersOngoing natural history studyLow CD4 countHIV-1 seropositiveImmunodeficiency virus infectionHIV-1 serostatusHealth care utilizationHIV-1 infectionHIV-positive serostatusNatural history studiesHealth care servicesCD4 countMore HIV